Chapter 38 Migraine Headache and Cluster Flashcards

KEY POINTS 1. The incidence of migraines in females increases into the early forties. 2. Consuming more than about 400 mg of caffeine per day can predispose to chronic migraines. 3. Basilar migraine can present with mental status changes. 4. Vasoconstrictor drugs, such as triptans, are contraindicated in basilar migraine. 5. Analgesic overuse (use of analgesics 10 or more days per month) can lead to chronic daily migraine. 6. The trigeminal autonomic cephalalgias include cluster, hemicr

1
Q

Migraine headache

A

represents a very common benign headache syndrome; it is sometimes referred to as a vascular headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The pain-generating structures of the head include

A

venous sinuses, meningeal and large cerebral arteries, basal meninges, muscles, skin, and cranial nerves V, IX, and X.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

trigeminovascular system

A

A plexus of largely unmyelinated fibers arises from the
trigeminal ganglion (cranial nerve V) and innervates the
cerebral and pial arteries, the venous sinuses, and the dura
mater

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The neurons in the trigeminovascular

system contain

A

substance P, one of the major nociceptive neurotransmitters of primary sensory neurons; calcitonin gene-related peptide (CGRP), which causes vasodilatation and when infused intravenously into susceptible individuals triggers headache; and neurokinin A, which is similar in structure and function to substance P.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When the trigeminal ganglion is stimulated and causes antidromic activation of the trigeminovascular system,

A

these peptide neurotransmitters are released near the
blood vessels they innervate; this results in vasodilatation
with consequent extravasation of plasma, or so-called sterile
neurogenic inflammation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Leakage of plasma proteins

from the dilated blood vessels in turn stimulates

A

the trigeminal nerve endings and causes nociceptive orthodromic signals to the trigeminal ganglion—the end result of this sterile neurogenic inflammation is the perception of pain in and around the head.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Neurogenic inflammation is

blocked by

A

substances that act as agonists on a subset of serotonin (5-hydroxytryptamine, or 5-HT) receptors: the 5-HT1D and 5-HT1B receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The major drugs used to

abort acute migraine attacks

A

agonists at the 5-HT1D/1B receptors. Drugs that act as agonists at these sites are thought to reduce neurogenic inflammation by inhibiting the trigeminal nerve endings and by their actions on blood vessels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Agonists at the 5-HT1D/1B receptors

include

A

ergot alkaloids (ergotamine, dihydroergotamine) and triptans (sumatriptan and others).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

stimulation of the trigeminal ganglion, through antidromic release of neurotransmitters, results in

A

increased cerebral and extracerebral blood flow.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Stimulation of the

dorsal raphe nucleus

A

serotonergic nucleus in the midbrain, also increases cerebral blood flow.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

stimulation of the nucleus caeruleus

A

the major source of central noradrenergic input, causes a decrease in cerebral blood flow.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Interneurons in the spinal cord and brainstem that are part of the descending pain modulation system use what as neurotransmitters?

A

enkephalins and g-aminobutyric acid (GABA) as neurotransmitters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

An
ascending serotonergic pathway in the midbrain raphe region
relays painful stimuli to the

A

ventroposteromedial (VPM) thalamus via the quintothalamic tract.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

A descending endogenous

pain modulating system originates in the

A

periaqueductal gray region of the midbrain, one of whose major relay structures is the nucleus raphe magnus in the medulla. After this relay, the descending pain modulating system connects with the spinal tract of the trigeminal nerve and the dorsal horns of the first through third cervical nerves.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Stimulation of the periaqueductal gray region causes

A

headache. The major neurotransmitters of this pain-modulating system are norepinephrine, serotonin, and enkephalins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

migraine with aura it is thought that the cortex,

particularly the occipital cortex, is hyperexcitable. The cause of this hyperexcitability is

A

may relate to decreased intracellular magnesium levels, to a dysfunction of brain mitochondria, or to abnormal calcium channels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

The aura phase of migraine begins as

A

a wave of cortical neural excitation, accompanied by hyperemia, and is followed by an electrical wave of spreading neural depression and oligemia that advances at a rate of 2 to 6 mm/minute (a rate similar to that of the developing aura). During the oligemic phase, blood
flow remains above the ischemic threshold.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Dopamine receptor hypersensitivity

may be responsible for the

A

nausea, vomiting, hypotension, and dizziness that frequently accompany, and sometimes characterize, attacks of migraine. Antiemetics, most of which are dopamine receptor antagonists (especially at the D2 receptor), are frequently useful, and sometimes
effective in and of themselves in treating migraine
attacks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

The diagnosis of migraine is made by

A

a suggestive clinical history and a normal neurologic examination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

The classic description of migraine

A

that of a recurrent headache lasting 2 to 72 hr, of moderate to severe intensity, pulsating, aggravated by routine physical activity, and associated with nausea, emesis, photophobia, phonophobia, and/or osmophobia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

The major subtypes of migraine are

A

migraine with aura and migraine without aura

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

The most frequent migrainous aura consists of

A

visual symptoms such as bright spots, dark spots, tunnel vision, or zigzag lines (fortification spectra). Other common auras include numbness or paresthesias in one arm or side of the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

The aura is followed (or sometimes accompanied) by

A

an intense, crescendo head pain, frequently unilateral or retro-ocular; it may be described as pounding, throbbing, pressure-like, exploding, stabbing, or vise-like

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

status migrainosus

A

the headache becomes intractable and lasts a week or longer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

basilar migraine

A

A migraine whose aura seems to originate in the brainstem

or involve both hemispheres

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

A typical aura in basilar migraine might present

A

with bilateral visual loss or blindness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

basilar migraine patients may complain

of

A

vertigo, dysarthria, diplopia, tinnitus, ataxia, a decreased
level of consciousness, or bilateral sensory (paresthesias)
or subjective motor symptoms (there should be no objective weakness); sometimes nausea and emesis are
prominent. Some patients present with other types of
auras such as a dysphasia, and as such may resemble a
transient ischemic attack (TIA), a stroke, or an evolving
neurologic catastrophe.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Exertional migraines

A

Some patients develop severe headache, sometimes described as exploding, related to exertion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

ophthalmoplegia

A

a severe ocular headache that presents with
ophthalmoplegia (usually of the oculomotor nerve and
includes a dilated pupil. The ophthalmoplegia can last
hours to months and is now believed to represent an inflammatory neuritis or the Tolosa–Hunt syndrome.10
Painful ophthalmoplegia usually has a dramatic presentation and always warrants a careful evaluation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Migraine without Aura

A

At least five headache attacks: Headaches last 4–72 hr if untreated. Has at least two of the following, but not weakness: Unilateral pain, Pulsating, Intensity is moderate to severe. Aggravated by routine physical activity
Has at least one of the following: Phonophobia, Photophobia, Nausea, Emesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Migraine with Aura

A

At least two headache attacks that also fulfill the characteristics of migraine without aura. Headaches usually follow the aura but may begin with it and last 4–72 hr if untreated. Has at least one of the following reversible symptoms (lasting 4 min to 60 min), but no weakness
Positive or negative visual symptoms such as scintillating scotomas, blind spot (scotoma), blurred vision, zigzag lines, homonymous hemianopsia. Positive or negative sensory symptoms such as tingling or numbness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Basilar Migraine

A

At least two attacks of migraine with an aura whose symptoms are reversible and localize to the brainstem or are bihemispheric, but without weakness
Symptoms can include: Dysarthria, Dizziness or vertigo
Bilateral visual symptoms, including temporary blindness
Diplopia, Nystagmus, Ataxia, Decreased level of consciousness, Bilateral paresthesiae, Tinnitus with or without decreased hearing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Aura without Headache

A

At least two attacks of symptoms typical of auras, but not weakness, such as visual, sensory or speech disturbances that resolve within 1 hr and are
not followed by a headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Hemiplegic Migraine

A

At least two attacks of migraine with a reversible aura of motor weakness that can last 1 hr to days
Also includes one of the following: Positive or negative visual symptoms, Positive or negative sensory symptoms
Dysphasia or dysarthria, Frequently accompanied by symptoms typical of basilar migraine. If at least one first- or second-degree relative has a migrainous aura that includes motor weakness, it is familial hemiplegic migraine and is associated with a mutation in the neuronal calcium channel. If no first- or second-degree relative has a migrainous aura that includes motor weakness, it is sporadic hemiplegic migraine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Migraines can be treated

A

abortively (after they start) or
prophylactically (with daily medication aimed at reducing
the frequency or intensity of the headaches).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Triptans (Imitrex, Maxalt, Zomig, Frova, Relpax,

Amerge, and others)

A

5-HT1D/1B receptor agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

How are Triptans dosed?

A

A second dose of the same preparation, taken 2 to 24 hr after the first, may again provide significant relief. A
triptan should not be used again for at least 24 hr after
the second dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Triptans should not be administered

within 24 hr of another substance with

A

vasoconstricting
properties (e.g., another triptan, ergotamine, dihydroergotamine,
or isometheptene).

40
Q

Triptans should not be

administered within 2 weeks of discontinuation of a

A

monoamine oxidase inhibitor or methysergide.

41
Q

Triptans should not be prescribed to patients with

A

ischemic or other heart disease or uncontrolled hypertension; they should be avoided in patients with complicated auras such as dysphasias and confusional states and in basilar migraine

42
Q

major side effects of triptans

A

sensation of chest pressure, flushing, tingling,

dizziness, and dysphoria. These usually resolve in less than 1 hr.

43
Q

Ergotamine tartrate

A

older drug with 5-HT agonist activity that also is very effective for migraine.
One to 2 tablets are taken at the onset of the headache or aura, followed by 1 tablet every 30 min until the headache is gone or until a maximum of 5 tablets per headache or 10 tablets per week have been consumed

44
Q

Isometheptene (Midrin)

A

effective drug with 5-HT agonist and sympathomimetic (vasoconstrictive) activity. Midrin also contains dichloralphenazone,
a mild sedative-hypnotic drug similar to chloral hydrate. One to 2 capsules are taken at the onset of the headache or aura, followed by 1 capsule every hour until the headache is gone or until a maximum of 5 capsules per headache or 10 capsules per week have been consumed

45
Q

If consumed in excess, ergotamine-containing preparations can cause

A

vasospastic complications and are emetogenic.

46
Q

Preparations containing butalbital (such as Fioricet,

which also contains acetaminophen and caffeine, or Fiorinal, which contains aspirin and caffeine

A

are effective
One to two tablets can be taken every 4 hr as needed. Barbiturate-containing preparations
cause drowsiness and can be habit forming if used
excessively

47
Q

Narcotic-containing preparations, such as those with codeine, hydromorphone, or hydrocodone (in combination with aspirin or acetaminophen)

A

should be used only as drugs of last resort. Narcotics bind opiate receptors and mask pain, but they do not bind serotonin receptors and therefore do not interrupt
the putative pathophysiologic mechanism of migraine.

48
Q

Antinauseants

A

prochlorperazine, chlorpromazine,
or metoclopramide, by virtue of their effect on
serotonin receptors, are effective against migraine pain. Their action as antagonists of the D2 dopamine receptor helps control the associated gastrointestinal symptoms
and this makes them excellent adjuvant drugs

49
Q

Dihydroergotamine (DHE)

A

generally administered
parenterally but also is available as a 4 mg/mL nasal spray. Administered by the intravenous or intramuscular route, the dose should not exceed 2 to 3 mg in 24 hr.

50
Q

Dihydroergotamine (DHE) indication

A

the drug of choice for treatment of status

migrainosus.

51
Q

Nonsteroidal anti-inflammatory drugs (NSAIDs)

A

work for some patients with mild to moderate
migraine pain. Ketorolac, which can be administered
intramuscularly, and indomethacin, which also is
available as a suppository, may be particularly useful.
Aspirin, particularly combined with acetaminophen and caffeine (Excedrin),
remains an effective and inexpensive over-the-counter
treatment.

52
Q

Cambia

A

diclofenac
combined with potassium bicarbonate. use for
the treatment of migraine.

53
Q

Cambia indications

A

It is a drug worth considering
in patients in whom vasoconstricting drugs are
contraindicated or who cannot tolerate the side effects
of vasoconstricting drugs.

54
Q

The chronic use (averaging at least 10 times per month
over a prolonged period of time) of any of the triptans,
NSAIDs, acetaminophen, butalbital, narcotics, ergotamine, DHE, and isometheptane can lead to

A

development of a medication overuse, or rebound, headache syndrome.

55
Q

Beta-blockers

A

propranolol (60 to 80 mg once per day), metoprolol,
atenolol, timolol, and nadolol, are frequently effective first-line prophylactic drugs; propranolol and timolol are FDA approved for migraine prophylaxis

56
Q

Beta-blockers Side effects

A

dizziness from bradycardia or hypotension, fatigue,
depression, worsening of symptoms in patients with
asthma or chronic obstructive pulmonary disease, gastrointestinal
distress, blunting of hypoglycemic symptoms
in patients with diabetes, and vivid dreams.

57
Q

Anticonvulsants

A

valproic acid (Depakote and
Depakote ER) and carbamazepine have been used as prophylaxis against migraine. Depakote
and Topamax are FDA approved for migraine
prophylaxis.

58
Q

Depakote ER

A

The usual starting dose for Depakote ER
is 500 mg per day; the dose should be adjusted as necessary
at 2- to 4-week intervals

59
Q

Valproic acid Side Effects

A

weight gain, hair loss, tremor, abdominal distress, and easy bruisability.

60
Q

Topamax

A

an inhibitor of carbonic anhydrase and it has been reported to be useful in treating the syndrome of idiopathic increased intracranial pressure
(previously called pseudotumor cerebri).

61
Q

Frequent side effects of Topamax

A

mental confusion and paresthesia; another is weight loss

62
Q

Antidepressants, particularly amitriptyline

A

at a starting dose of 10 to 25 mg at bedtime, are very active prophylactic drugs. Most patients who respond to tricyclic antidepressants (amitriptyline, nortriptyline, imipramine, or desipramine) usually do so at doses of 25 to
200 mg at bedtime; occasionally a patient may require more

63
Q

The major side effects from tricyclics relate to

A

their anticholinergic action and include a dry mouth,

excessive daytime sleepiness, dizziness, urinary retention, glaucoma, cardiac arrhythmias, and photosensitization.

64
Q

The specific serotonin reuptake inhibitors

SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs

A

tried in patients who do not respond or who develop intolerable side effects from tricyclic drugs.

65
Q

The major side effects of the SSRIs and SNRIs

A

jitteriness, tremors, gastrointestinal distress,

decreased libido, and occasionally headaches

66
Q

SSRIs and SNRIs are relatively contraindicated in

patients who use

A
triptans, as they may suffer from excessive
serotonin stimulation (serotonin syndrome).
67
Q

Calcium channel blockers

A

verapamil, are occasionally
useful as prophylactic agents. Calcium channel blockers are worth a try when firstline agents fail; they also appear to be more useful in patients with cluster headaches.

68
Q

Lithium carbonate

A

useful in patients with frequent

migraines who do not respond to more traditional prophylactic regimens

69
Q

The major indication for lithium

A

treatment of an ongoing cluster headache.

70
Q
Individualized injections of botulinum toxin A into the
pericranial muscles (frontalis, temporalis, and glabellar muscles)
A

has been reported to increase significantly the
number of headache-free days in some patients with
chronic migraine. The beneficial effect may last up to 90 days postinjection

71
Q

self-help strategies that can minimize the incidence of migraines

A

If the patient consumes caffeinated beverages (coffee, tea, soda, cocoa), total caffeine should be limited to less than 400 mg per day (to avoid caffeinism) and the intake should include weekends, vacations, and holidays
(to avoid a caffeine withdrawal headache).

72
Q

foods high in tyramine

(a substance metabolized to serotonin), which is thought to play a role as a migraine trigger, can be avoided.

A

chocolate, aged cheeses,

yogurt, sour cream, soy sauce, chicken liver, banana, avocado, nuts, and yeast extracts (including beer).

73
Q

Foods high in nitrates can be avoided, as these might
precipitate a migraine by virtue of their vasodilating
properties.

A

Some foods high in nitrates include processed
meats (hot dogs, salami, bacon, ham, sausage,
corned beef) and other canned, smoked, or aged meats.

74
Q

patients are sensitive to certain food additives

A

monosodium glutamate, frequently
used in restaurants and added to cooked,
packaged, and canned foods as a flavor enhancer, and
aspartame (NutraSweet). These substances contain
glutamate, an excitatory neurotransmitter.

75
Q

migraneurs are sensitive to alcoholic beverages.

A

Alcohol tends to dilate blood vessels.

76
Q

trigeminal autonomic cephalalgias (TAC)

A

represent a
group of three headache disorders characterized by the occurrence
of pain in the distribution of the first division of
the trigeminal nerve accompanied by prominent parasympathetic
autonomic features in the same distribution.

77
Q

trigeminal autonomic cephalalgias (TAC) examples

A

These headaches are: cluster, hemicrania (paroxysmal hemicrania
and hemicrania continua), and short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT).

78
Q

trigeminal autonomic cephalalgias (TAC) presents

A

with some combination of ocular redness, tearing, swelling, miosis, or ptosis; additional symptoms can include
forehead sweating and rhinorrhea

79
Q

trigeminal autonomic cephalalgias (TAC) durations

A

Cluster headache lasts longest and presents with circadian periodicity but, overall clusters tend to occur relatively infrequently, such as yearly. SUNCT have the shortest duration but a high frequency of attacks. The duration and frequency of paroxysmal hemicrania is intermediate. Hemicrania continua is characterized by continuous pain with exacerbations.

80
Q

Cluster headache is diagnosed by

A

suggestive clinical history
and a normal neurologic examination. Typically, severe pain, which lasts between 15 and 90 min, awakens the patient. The pain is unilateral and periorbital; it may include
the temple, forehead, and cheek (the distribution of
the first division of the trigeminal nerve).

81
Q

Cluster headache accompanied by

A

lacrimation, conjunctival injection, nasal stuffiness, ptosis (with or without eyelid edema), and miosis ipsilateral to the pain.

82
Q

Unlike patients with migraine, who seek

a dark, quiet environment, patients with cluster tend to

A

pace, scream, or appear agitated; nausea and vomiting are uncommon.

83
Q

The major limitation of drugs aimed at interrupting the cluster (drugs used in migraine prophylaxis) is

A

their slow onset of action, with most requiring 2 to 4 weeks to demonstrate
activity at the initial dose, and similar intervals for
subsequent dose adjustments.

84
Q

drugs are useful for interrupting the cluster-

Calcium channel blockers

A

Calcium channel blockers, such as verapamil (Verapamil usually requires administration at relatively high doses, 240 to 480 mg/day, to be effective.)

85
Q

drugs are useful for interrupting the cluster - Anticonvulsants

A
valproic acid (Depakote and
Depakote ER) and carbamazepine can be useful to help abort a cluster. The usual starting dose for Depakote ER is 500 mg per day; the dose should be adjusted as
necessary at 2- to 6-week intervals. Valproic acid can
cause weight gain, hair loss, tremor, and abdominal distress.
86
Q

drugs are useful for interrupting the cluster - Lithium carbonate

A

can be useful in patients with cluster;
in fact, cluster remains the major indication for
lithium in the treatment of headaches.

87
Q

drugs are useful for interrupting the cluster -Antidepressants

A

amitriptyline at a starting
dose of 10 to 25 mg at bedtime. Tricyclics help induce sleep, which
may constitute one of the mechanisms by which they
help patients with cluster.

88
Q

The major side effects from

tricyclics

A

relate to their anticholinergic effects and include a dry mouth, excessive daytime sleepiness, dizziness,
urinary retention, glaucoma, cardiac arrhythmias,
and photosensitization.

89
Q

drugs are useful for interrupting the cluster - Beta-blockers

A

propranolol, metoprolol, atenolol, timolol, and nadolol, are also used frequently for cluster. In most healthy people 60 to 80 mg once per day of a long-acting propranolol preparation can be started and the dosage can be adjusted as necessary

90
Q

Beta-blockers Side Effects

A

dizziness from bradycardia or hypotension, fatigue, depression, worsening of symptoms in patients with asthma or chronic obstructive pulmonary
disease, gastrointestinal distress, blunting of hypoglycemic symptoms in patients with diabetes, and vivid dreams.

91
Q

Corticosteroids are useful as adjuvants to other drugs in breaking a cluster

A

They should be started simultaneously with one of the other prophylactic drugs. Corticosteroids
are to be used for a limited time

92
Q

drugs are useful for interrupting the cluster -NSAIDs

A

indomethacin appears to be more
active than others. It also can be used in anticipation of a
headache to block its onset. Indomethacin can be administered
in doses up to 150 mg/day but tends to irritate the
gastric mucosa

93
Q

Treatment of an Acute Cluster Headache

A

inhaled oxygen remains the standard
for treatment of an acute cluster headache.31 Oxygen
should be administered at 12 L/minute through a nonrebreather mask for 15 min as soon after the onset of the attack as feasible.

94
Q

Paroxysmal hemicrania

A

The syndrome consists of frequent, unremitting, unilateral headaches exhibiting a frequency of a few to more than 20 per day; the headaches last 5 to 45 min each. The pain, throbbing or boring, is localized on one side of the
head, around the eye and temple (in the distribution of
the first division of the trigeminal nerve). As in cluster, the pain is accompanied by autonomic (parasympathetic) phenomena: redness and tearing of the eye, eyelid swelling, nasal congestion, and/or rhinorrhea.

95
Q

The hallmark of hemicrania

A

it responds completely and dramatically to indomethacin, which can be administered in doses up
to 150 mg/day and, as long as it is tolerated, can be used for long periods of time.

96
Q

short-lasting unilateral neuralgiform headache with conjunctival injection (SUNCT)

A

Bursts of stabbing, throbbing, or burning
pain around the eye or temple, lasts 5 seconds to 5 min and occurs in paroxysms of up to 30 per hr (with an average of 5 to 6/hr). Here too, the pain is accompanied by autonomic (parasympathetic) phenomena in the distribution of the first division of the trigeminal nerve: redness and tearing of the eye, eyelid swelling, nasal congestion, and/or rhinorrhea

97
Q

short-lasting unilateral neuralgiform headache with conjunctival injection treatment

A

prophylactic treatment with anticonvulsants

including lamotrigine and oxcarbazepine